Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study
Oliver G. Ottmann(Cardiff University), Steven Coutré(Georgetown University), Andreas Hochhaus(Jena University Hospital), Ashwin Gollerkeri(Peter MacCallum Cancer Centre), Richard A. Larson(Urbana University), Giovanni Martinelli(University of Bologna), Giovanna Rege‐Cambrin, François Guilhot(Centre Hospitalier Universitaire de Poitiers), Jerald P. Radich(University of Washington), Hervé Dombret(University of London Institute in Paris), Bengt Simonsson(Uppsala University Hospital), Anne Marie Apanovitch(Bristol-Myers Squibb (United States))
Cited by 370
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
|Leukemia|2022|3.8k